Abstract: Embodiments of the present disclosure include a multi-inlet fracturing head (MIFH) having a first inlet channel extending through a body of the MIFH, the first inlet channel being substantially perpendicular to an axis of the MIFH and directing fluid into a first flow passage of the MIFH. The MIFH also includes a second inlet channel extending through the body of the MIFH, the second inlet channel being at an angle relative to the axis and directing fluid into the first flow passage of the MIFH.

Abstract: Embodiments of the present disclosure include a system for coupling objects in a wellbore includes a unidirectional valve having a body. The body includes two or more body lugs extending radially outward, each body lug of the two or more body lugs extending at least a portion of a circumferential distance of the body. The system also includes a tubing hanger having a bore that receives the unidirectional valve. The bore includes an axial restraint system that receives the two or more body lugs and blocks axial movement of the unidirectional valve in a first position and enables axial movement of the unidirectional valve in a section position, the unidirectional valve being non-threadingly coupled to the tubing hanger.

Abstract: Embodiments of the present disclosure include a multi-inlet fracturing head (MIFH) having a first inlet channel extending through a body of the MIFH, the first inlet channel being substantially perpendicular to an axis of the MIFH and directing fluid into a first flow passage of the MIFH. The MIFH also includes a second inlet channel extending through the body of the MIFH, the second inlet channel being at an angle relative to the axis and directing fluid into the first flow passage of the MIFH.

Abstract: Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Abstract: Embodiments of the present disclosure include a system for installing a slip hanger assembly in a wellbore with a slip bowl comprising an aperture extending from an outer diameter of the slip bowl. The system also includes a slip coupled to the slip bowl, the slip comprising teeth on an inner face and a slot for receiving a shear pin extending through the aperture. The system further includes a running tool coupled to the slip bowl. The system includes a housing coupled to the running tool, the housing including a cylinder for receiving a reciprocating piston, the piston being movable between a first position and a second position, wherein the slip is in stored position while the piston is in the first position and an engaged position when the piston is in the second position.

Abstract: Systems, devices and processes improve the reliability of wireless communications within a video production system by providing a map or other graphical interface showing the relative locations of video capture devices, access points and/or other network devices. The graphical presentation can be used to provide instructions to direct the manual or automatic changing of positions to thereby improve signal quality for the device.

Abstract: A system includes a computer that is programmed to receive one or more media streams, each from a respective one of a one or more media capture devices, and to receive, from a client device, for each of the one or more media streams, state data including at least one of an active and a potential state of the media stream. The computer is further programmed to disconnect from the client device, and then, upon reconnecting to the client device, to provide at least one of the media streams and the state data to the client device.

Abstract: Systems, devices and automated processes reduce the effects of unwanted interruption during video encoding by reserving header space at the outset of video encoding. This reserved space can be progressively filled on any periodic or other basis as encoding continues so that a recent header is always available. If an interruption occurs, only the video content encoded after the last header write will be lost, thereby greatly reducing the effects of the interruption.

Abstract: Embodiments of the present disclosure include a multi-inlet fracturing head (MIFH) having a first inlet channel extending through a body of the MIFH, the first inlet channel being substantially perpendicular to an axis of the MIFH and directing fluid into a first flow passage of the MIFH. The MIFH also includes a second inlet channel extending through the body of the MIFH, the second inlet channel being at an angle relative to the axis and directing fluid into the first flow passage of the MIFH.

Abstract: A hydraulic fracturing assembly includes a frac tree that mounts to a wellhead. An injection tee mounts to the tree, the injection tee having an axial injection tee bore that registers with an axial flow bore of the frac tree. A single inlet passage in the injection tee extends from a flowline mounting face on an exterior portion of the injection tee downward and inward into a junction with the axial flow bore. A wear resistant inlet passage sleeve extends from the mounting face of the injection tee a selected distance into the inlet passage. The inlet passage sleeve is of a harder material than the injection tee. A flowline connects to the mounting face to deliver fluid into the inlet passage. The flowline has an upward curved section and an inclined section that joins the curved section and extends downward and outward away from the injection tee.

Abstract: Shrinkage compensated seal assemblies and methods of compensating for shrinkage of a seal due to temperature variations, are provided. According to an exemplary shrinkage compensated seal assembly, the assembly includes a seal, a first compression member for engaging the upper surface of the seal, a second compression member for engaging the lower surface of the seal, and a plurality of pin members each having an elongate body and a head portion. The elongate body of each separate one of the plurality of pin members slidably extends through a different one of a plurality of sets of apertures in the first compression member, the seal, and the second compression member to provide for maintaining a substantially constant pressure on the seal at given pressure under varying temperature conditions that result in variations in the volume size of the seal.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

Abstract: This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R1, R2 and R3 are as defined in this specification.

Abstract: Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.